Passage BIO, Inc. SEC filings PASG
Passage BIO, Inc. has 443 filings in SEC EDGAR's recent list, going back to Sep 6, 2019. Its latest annual report, Form ARS, was filed on Apr 7, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 10, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Nov 6, 2026 (officer or director change, shareholder vote results). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| EFFECT | Filing | Oct 9, 2026 | — |
| 425 | Filing | Sep 3, 2026 | — |
| 425 | Filing | Jul 22, 2026 | — |
| 425 | Filing | Jun 24, 2026 | — |
| 425 | Filing | Jun 24, 2026 | — |
| EFFECT | Filing | Apr 16, 2024 | — |
| CORRESP | Letter to the SEC | Apr 12, 2024 | — |
| UPLOAD | Letter from the SEC | Mar 7, 2024 | — |
| EFFECT | Filing | Apr 14, 2022 | — |
| POSASR | Filing | Mar 3, 2022 | — |
| EFFECT | Filing | Jan 21, 2021 | — |
| CORRESP | Letter to the SEC | Jan 19, 2021 | — |
| CORRESP | Letter to the SEC | Jan 19, 2021 | — |
| UPLOAD | Letter from the SEC | Dec 22, 2020 | — |
| DRS | Filing | Dec 18, 2020 | — |
| EFFECT | Filing | Feb 27, 2020 | — |
| SEC STAFF LETTER | Filing | Feb 26, 2020 | — |
| CORRESP | Letter to the SEC | Feb 25, 2020 | — |
| CORRESP | Letter to the SEC | Feb 25, 2020 | — |
| CERT | Filing | Feb 25, 2020 | — |
| 8-A12B | Filing | Feb 18, 2020 | — |
| CORRESP | Letter to the SEC | Feb 7, 2020 | — |
| SEC STAFF LETTER | Filing | Jan 31, 2020 | — |
| SEC STAFF LETTER | Filing | Jan 17, 2020 | — |
| DRSLTR | Filing | Jan 10, 2020 | — |
| DRS/A | Filing | Jan 10, 2020 | — |
| UPLOAD | Letter from the SEC | Jan 3, 2020 | — |
| DRS | Filing | Dec 6, 2019 | — |
| D | Filing | Sep 6, 2019 | — |
Showing 29 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Biological Products, (No Diagnostic Substances) (SIC 2836)
- Listed as
- PASG (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Philadelphia, PA
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 1787297
Other Biological Products, (No Diagnostic Substances) companies
- Amgen Inc AMGN
- Gilead Sciences, Inc. GILD
- Moderna, Inc. MRNA
- Argenx SE ARGX
- Revolution Medicines, Inc. RVMD
- Biogen Inc. BIIB
- BioNTech SE BNTX
- Exelixis, Inc. EXEL
All 182 Biological Products, (No Diagnostic Substances) companies
Source: SEC EDGAR filings. This is company-reported data, not investment advice.